1. 8PSAFETY OF IMPRIME PGG, A NOVEL INNATE IMMUNE MODULATOR, IN ADULTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC). (November 2014) Authors: Thomas, M.; Schneller, F.; Sadjadian, P.; Hao, Z.; Mattson, P.; Lowe, J.; Huhn, R.; Braun, A.; Taitt, C. Journal: Annals of oncology Issue: Volume 25(2014)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. POINT-OF-NEED DIAGNOSTICS: BIOSURVEILLANCE WITH A DEVICE2CLOUD CAPABILITY IN SIERRA LEONE. (12th February 2017) Authors: Ansumana, Rashid; Taitt, C.; Lamin, J.M.; Jacobsen, K.H.; Mulvaney, S.P.; Leski, T.; Bangura, U.; Stenger, D. Journal: BMJ global health Issue: Volume 2(2017)Supplement 2 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗